Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 4, 1997, Pages 771-776

  Wenz, Frederick ^a   Lohr, Frank ^a   Flentje, Michael ^a   Rudat, Volker ^a   Dietz, Andreas ^a   Wannenmacher, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Accelerated hyperfractionated radiochemotherapy; Flow cytometry; Head and neck tumor; Predictive assay; Proliferating cell nuclear antigen; Squamous cell carcinoma

Indexed keywords

CYCLINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL POPULATION; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PLOIDIES; PREDICTIVE VALUE OF TESTS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE;

EID: 0030938311     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00024-2     Document Type: Article

References (22)

1. Beahrs, O. H.; Henson, I. E.; Hutter, R. V. F.; Myers, M. H., eds. American Joint Committee for Cancer Staging and End Result Reporting: Manual for staging of cancer, 3rd ed. Philadelphia, PA: J. B. Lippincott, 1988:34-35.
2. Begg, A. C; McNally, N. J.; Shrieve, D. C.; Kärcher, H. A method to measure the duration of DNA-synthesis and the potential doubling time from a single sample. Cytometry 6:620-626; 1985.
3. Begg, A. C.; Hofland, I.; Bartelink, H.; Schraub, S.; Bontemps, P.; Le Fur, R.; Van den Bogaert, W.; Caspers, R.; Van Glabbeke, M.; Horiot, J. C. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim report. Int. J. Radiat. Oncol. Biol. Phys. 19:1449-1453; 1990
4. Begg, A. C.; Hofland, I.; van Glabekke, M.; Bartelink, H.; Horiot, J. C. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851. Semin. Radiat. Oncol. 2:22-25; 1992.
5. Bourhis, J.; Wilson, G.; Wibault, P.; Bosq, J.; Chavaudra, N.; Janot, F.; Luboinski, B.; Eschwege, F.; Malaise, E. P. In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 26:793-799; 1993.
6. Bravo, R.; MacDonald-Bravo, H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA-replication sites. J. Cell. Biol. 105:1549-1554; 1987.
7. Chauvel, P.; Courdi, A.; Gioanni, J.; Vallicioni, J.; Santini, J.; Demard, F. The labelling index: A prognostic factor in head and neck tumors. Radiother. Oncol. 14:231-237; 1989.
8. Dische, S.; Saunders, M. Continuous hyperfractionated accelerated radiotherapy (CHART): An interim report upon late morbidity. Radiother. Oncol. 16:67-74; 1989.
9. Fietkau, R.; Iro, H.; Altendorf-Hofmann, A.; Sauer, R. Prognostic value of cellular DNA content and S-phase fraction in head and neck squamous cell carcinomas in relation to different treatment modalities. Radiat. Oncol. Invest. 1:50-62; 1993.
10. Gatenby, R. A.; Kessler, H. B.; Rosenbaum, J. S.; Coia, L. R.; Moldofsky, P. J.; Hartz, W. H.; Broder, G. J. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14:831-838; 1988.
11. Goz, B. The effects of incorporation of 5-halogenated deoxyuridines into DNA of eukaryotic cells. Pharmacol. Rev. 29:249-272; 1978.
12. Joensuu, H. DNA flow cytometry in the prediction of survival and response to radiotherapy in head and neck cancer. A review. Acta Oncol. 29:513-516; 1990.
13. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
14. Lohr, F.; Wenz, F.; Haas, S.; Flentje, M. Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry. Cell Prolif. 28:93-104; 1995.
15. Saunders, M.; Dische, S.; Hong, A.; Grosch, E.; Fermont, D.; Ashford, R.; Maher, E. Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinomas of the head and neck region. Int. J. Radiat. Oncol. Biol. Phys. 17:1287-1293; 1989.
16. Silvestrini, R.; Diadone, M. G.; Gasparini, M. Cell kinetics as a persistent prognostic marker in node negative breast cancer. Cancer 56:1982-1987; 1985.
17. Sullivan, R. P.; Mortimer, G. Value of PCNA and Ki67 staining in breast cancer. J. Clin. Pathol. 46:188-189; 1993.
18. Wenz, F.; Lohr, F.; Flentje, M. Flow cytometric measurement of proliferating cell nuclear antigen (PCNA) in solid tumors. Strahlenther. Onkol. 4:235-242; 1994.
19. West, C. M. L.; Davidson, S. E.; Roberts, S. A.; Hunter, R. D. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br. J. Cancer 68:819-823; 1993.
20. Wilson, G. D.; Camplejohn, R. S.; Martindale, C. A.; Brock, A.; Lane, D. P.; Barnes, D. M. Flow cytometric characterization of proliferating cell nuclear antigen using the monoclonal antibody PC10. Eur. J. Cancer 28A:2010-2017; 1992.
21. Wilson, G. D.; Dische, S.; Saunders, M. I. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol. 36:189-197; 1995.
22. Withers, H. R.; Taylor, J. M. F.; Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.